Reviewed by
Dr. Lovedeep Singh Chauhan MS, MCh (Surgical Oncology) | Senior Surgical Oncologist Trained at Tata Memorial Hospital, Mumbai Practicing at Max Super Speciality Hospital, Mohali
This story is a composite educational narrative based on the typical journey of breast cancer patients treated with breast-conserving surgery and reconstruction. It is shared purely to help other patients understand the process, reduce fear, and make informed decisions.
No real patient's name, photograph, or identifiable detail is used. This content complies with the National Medical Commission (NMC) guidelines on medical ethics and does not serve as a promotional testimonial. If you or a loved one is facing a similar diagnosis, please consult a qualified surgical oncologist directly.
A breast cancer diagnosis changes everything in a single moment. The words land differently for every woman — some feel shock, some feel a strange calm, and many feel both at once. What comes next — the consultations, the scans, the decisions about surgery — can feel like navigating an entirely foreign world without a map.
This story follows Priya (name changed), a 42-year-old schoolteacher from a town near Chandigarh, who was diagnosed with early-stage breast cancer and went on to have breast-conserving surgery followed by reconstruction. Her journey — from the first lump she felt to her return to the classroom — is shared here so that other women facing a similar path feel less alone and more informed.
Breast cancer is the most common cancer among women in India. Yet awareness about breast-conserving surgery — an option that removes the tumour while preserving most of the breast — remains low, particularly in smaller cities and towns across Punjab and the wider region.
Priya first noticed a small, firm lump in her left breast during a routine self-examination. It was not painful, which is why she initially waited, hoping it would resolve on its own. After nearly six weeks, the lump was still there — slightly firmer, she thought, though she could not be certain.
Her family physician referred her to a surgical oncologist for evaluation. An ultrasound and mammogram were done the same week, followed by a core needle biopsy. Within ten days of that first referral, Priya had her diagnosis — invasive ductal carcinoma, Stage II, with no lymph node involvement detected on initial imaging.
She described that moment in the consultation room as surreal. "I kept thinking, I feel completely fine. How can something this serious be happening inside me?" This is one of the most important things to understand about early breast cancer — it frequently causes no pain, no visible change, and no obvious symptoms until it is found through examination or imaging.
At her first detailed surgical consultation, Priya was presented with two primary surgical options — a mastectomy (removal of the entire breast) or a breast-conserving surgery, also called a lumpectomy or wide local excision, which removes the tumour along with a margin of surrounding healthy tissue while preserving the rest of the breast.
Given her tumour size, its location, and the absence of multiple tumour sites in the breast, breast-conserving surgery was clinically appropriate for Priya. Her surgeon explained that when performed correctly with clear margins, breast-conserving surgery followed by radiation therapy provides equivalent long-term cancer control to mastectomy for early-stage disease in appropriately selected patients.
Priya asked what she felt was a very basic question — "Will it look normal afterwards?" The answer was not a simple yes or no. The surgical team explained that oncoplastic reconstruction — reshaping and reconstructing the breast tissue at the time of tumour removal — would be performed to ensure the best possible cosmetic outcome while achieving complete cancer removal.
This combination of oncological precision and reconstructive planning is a core part of modern breast cancer surgical care. Patients from across Punjab — including those travelling from Ludhiana, Patiala, and Mohali — are increasingly asking about this option as awareness grows.
Priya was admitted the morning of her surgery. The surgical team had pre-operatively marked the tumour site using ultrasound guidance, and a wire localisation procedure was done to precisely identify the tumour boundaries for the surgeon.
The breast-conserving surgery itself took approximately two and a half hours. The tumour was removed with a rim of healthy tissue around it — this surrounding margin is critical, as it confirms under microscopy that no cancer cells remain at the edges of the removed tissue. Simultaneously, a sentinel lymph node biopsy was performed, a procedure where the first one or two lymph nodes that drain the breast are removed and tested for cancer spread, avoiding the need to remove all underarm lymph nodes unless cancer is found in them.
The oncoplastic reconstruction was performed in the same operation. Using the remaining breast tissue, the surgical team reshaped and repositioned the breast to maintain its natural form as closely as possible. The result was a smaller, repositioned breast on the operated side, with plans to balance both sides later if Priya chose.
She woke up in the recovery room with a drain in place of a small tube to collect fluid from the surgical site — and less pain than she had anticipated.
The days between surgery and the final pathology report are often described by patients as the most emotionally difficult part of the entire journey. Priya was no different.
Her final histopathology report arrived seven days after surgery. The margins were clear — meaning the tumour had been completely removed with healthy tissue around it on all sides. The sentinel lymph nodes were negative for cancer. The tumour grade and receptor status (ER positive, PR positive, HER2 negative) were used to plan her next treatment steps.
[→ Read our guide on Histopathology Report Explained: What Tumour Grade, Margins, and Lymph Nodes Mean to understand what these terms mean for your own report]
Clear margins and negative lymph nodes are two of the most important outcomes after breast-conserving surgery. They significantly influence the next stage of treatment and the overall prognosis.
Because Priya had breast-conserving surgery rather than a full mastectomy, radiation therapy to the remaining breast tissue was a standard part of her treatment plan. This is not a sign that the surgery was incomplete — it is a routine and expected component of breast-conserving treatment that significantly reduces the risk of local recurrence.
She completed a course of radiation therapy over several weeks at a cancer centre accessible from her home. The side effects were manageable — some fatigue and mild skin changes in the treated area — and resolved over time.
Given her hormone receptor-positive status, she was also started on hormonal therapy (an aromatase inhibitor) for five years, which works by reducing the estrogen that her type of cancer cells feed on. This is a tablet taken daily — not chemotherapy — and is a very important part of long-term cancer control for receptor-positive breast cancers.
[→ Read our guide on Chemotherapy vs Targeted Therapy: Key Differences Every Patient Should Know to understand the difference between these treatment types]
Priya's physical recovery was relatively smooth. She was back to light household activity within three weeks and returned to her classroom eight weeks after surgery. But she was candid about the emotional recovery being slower and less linear.
There were days of genuine fear — particularly around follow-up scan dates, when the anxiety of "what if it has come back" returned strongly. There were days of grief over the change in her body, even though the reconstruction had gone well. There were also days of profound gratitude and a completely different relationship with time and with her own health.
She found it helpful to talk openly with her surgical oncologist at follow-up visits — not just about physical symptoms, but about her fears and questions. She also connected with other breast cancer patients through a local support group, which she described as invaluable.
Emotional recovery from cancer is not a straight line and does not follow a fixed timeline. It deserves as much attention as physical recovery.
Two years after her surgery, Priya remains disease-free. She attends six-monthly follow-up appointments, continues her daily hormonal therapy tablet, performs monthly self-examinations, and has annual mammograms as per her surveillance plan.
She returned to teaching and describes herself as a fundamentally changed person — more present, more patient with her students, and more willing to speak openly about breast cancer to the women around her. She has personally encouraged three of her colleagues to get mammograms after sharing her story.
Her outcome is not a guarantee for every patient — cancer treatment results depend on stage, biology, overall health, and many other clinical factors. But her journey demonstrates what is possible with early detection, correct surgical planning, and comprehensive follow-up care.
Early detection makes breast-conserving surgery possible. Tumours found at Stage I or II are far more likely to be candidates for lumpectomy than those found at advanced stages, where more extensive surgery may be unavoidable.
Breast-conserving surgery does not mean compromising on cancer control. When performed with clear margins and followed by appropriate radiation and medical therapy, it offers outcomes equivalent to mastectomy for early-stage disease.
Oncoplastic reconstruction is part of the surgery, not an afterthought. Planning reconstruction at the time of tumour removal gives better cosmetic results than trying to correct the defect later.
Emotional support is a medical need. Patients who feel supported, informed, and heard throughout their treatment cope better, adhere to treatment better, and recover better.
A second opinion is your right. If you have any doubt about the surgical recommendation you have received, consulting another surgical oncologist before proceeding is always appropriate and encouraged.
[→ Read our article on Second Opinion in Cancer: Why It Matters and How to Get One]
This article is intended solely for general patient education and awareness. The case described is a composite anonymised educational overview and does not represent any single identifiable patient. No real patient names, photographs, or identifying details have been used. This content does not constitute medical advice, a diagnosis, or a treatment recommendation for any individual. Decisions regarding CRS-HIPEC or any cancer treatment must be made through direct consultation with a qualified surgical oncologist based on individual clinical assessment. Dr. Lovedeep Singh Chauhan and this website do not claim guaranteed outcomes from any surgical procedure. Results vary based on cancer type, stage, patient health, and other clinical and biological factors.
This is a representative educational patient journey. All identifying details have been changed or composited to protect patient privacy. This article does not constitute medical advice
Dr. Lovedeep Singh Chauhan is a Consultant in Surgical Oncology at Max Super Speciality Hospital, Mohali (2023–present). He has received advanced training in cancer surgery from leading national institutes and has academic, clinical, and research experience across multiple subspecialties of surgical oncology.